Goodness Growth in Line with Expectations in Q2, Will Divest in NY
Management said investors can expect more clarity more clarity on the New York divestiture in
Harmony Biosciences Buys Zynerba Pharmaceuticals in $60M Deal
Harmony will fund the transaction from its existing cash on hand. Harmony Biosciences Holdings Inc.
Safe Harbor Losses Mount Despite Skyrocketing Revenue
SHF Holdings Inc. (Nasdaq: SHFS), which operates as Safe Harbor Financial, saw its revenue shoot
Tilt Revenue Falls as Focus Turns to Jupiter
Tilt Holdings Inc. (Cboe: TILT) (OTCQX: TLLTF) reported revenue fell to $41.6 million for the three months
Number of the Week: 23%
23% – Percentage of U.S. consumers that use concentrates Nearly a quarter of cannabis consumers
Predictions for Future Federal Cannabis Laws
By Griffen Thorne, Attorney at Harris Bricken Most Americans favor federal cannabis legalization. Nearly all Americans support medical
Enveric Biosciences Loses $6.4 Million in Q2, Announces Cost-Reduction Plan
The company said it progressed toward obtaining federal patents on synthetic psychedelic drugs. Florida-based Enveric
Glass House Shrinks Losses to $25M in Q2 on Revenue Increase
Wholesale biomass sales for Glass House were up 358% year-over-year. California-based Glass House Brands (Cboe:
Clever Leaves Revenue Rises, Costs Fall in Q2
Clever Leaves Holdings Inc. (Nasdaq: CLVR) saw a 21% year-over-year rise for revenue in its
Michigan Cannabis Sales Break Another Record in July, Likely to Top $3B in 2023
Prices have also rebounded since January. This story was republished with permission from Crain’s Detroit Business and